Wesley Won't Talk, Bausch Might Walk

Cecil, Mark
May 2000
Mergers & Acquisitions Report;05/29/2000, Vol. 13 Issue 22, p1
Discusses the tender offer of Bausch & Lomb Inc. to Wesley Jessen Vision Care Inc. Reasons for the hesitation of Wesley on Bausch's offer; Amount offered by Bausch to Wesley; Why a three-party bid is unlikely.


Related Articles

  • Lens maker trapped in bull's-eye. Podmolik, Mary Ellen // Crain's Chicago Business;05/08/2000, Vol. 23 Issue 19, p1 

    Reports on Bausch and Lomb Inc.'s hostile takeover bid for Wesley Jessen VisionCare Inc. Wesley's plan to acquire Ocular Sciences Inc.; Wesley's role in helping independent optometrists with marketing and advertising programs; Underwriting of continuing education programs; Wesley's share in the...

  • Financings roundup.  // Medical Device Daily;8/7/2012, Vol. 16 Issue 152, p7 

    The article reports on the amendment to Rochester, New York-based Bausch + Lomb's tender offer to buy for cash up to 300 million dollars of its outstanding 9% senior notes due 2015.

  • B&L commences tende offer to purchase up to $300m in notes.  // Medical Device Daily;7/24/2012, Vol. 16 Issue 142, p4 

    The article reports on the launch of a tender offer by Bausch & Lomb for the purchase of its outstanding 9% senior notes due 2015.

  • Deals roundup.  // Medical Device Daily;7/30/2007, Vol. 11 Issue 143, p3 

    This section offers news related to the health care industry. Shareholders of Bausch & Lomb have expressed dissatisfaction over the company's plan to reject Advanced Medical Optics bid in favor of Warburg Pincus. Conroe Medical Center was acquired by Montecito Medical Investment Co. and ING...

  • Financings roundup.  // Medical Device Daily;10/22/2007, Vol. 11 Issue 202, p3 

    The article reports that Bausch & Lomb (B&L) has extended the expiration date of its offers for its debt securities and its convertible debt securities to October 26, 2007. In September 2007, B&L stated that it is undertaking cash tender offers and consent solicitations for four series of...

  • Financings roundup.  // Medical Device Daily;9/21/2007, Vol. 11 Issue 181, p4 

    The article provides information on the stock market offerings of Bausch & Lomb (B&L) in 2007. B&L is initiating cash tender offers and consent solicitations for four series of outstanding debt securities and two series of outstanding convertible debt securities. The offers and solicitations are...

  • Bausch & Lomb Tops Valeant with US$500 M Bid for ISTA. Cartwright, Heather // PharmaDeals Review;2012, Vol. 2012 Issue 4, p49 

    After rejecting a hostile US$7.50 per share takeover bid from Valeant Pharmaceuticals International earlier in 2012, ISTA Pharmaceuticals has accepted a US$9.10 per share offer from Bausch & Lomb (B&L), which equates to a total deal value of approximately US$500 M. The transaction, which has...

  • B&L Gets 2nd Acquisition Suitor as AMO Tops Warburg's Bid.  // Vision Monday;7/23/2007, Vol. 21 Issue 8, p14 

    The article reports on the acquisition bid of Advanced Medical Optics (AMO) for Bausch & Lamb(B&L). AMO offered B&L $45 in cash and $30 in its own stock for every B&L share to reach $4.3 billion in July 2007 which exceeds the offer of Warburg Pincus of $65 per share totaling to $3.7 billion plus...

  • Deals roundup.  // Medical Device Daily;7/26/2007, Vol. 11 Issue 141, p6 

    This article reports on the decision of Advanced Medical Optics (AMO) to reaffirm its bid for rival Bausch & Lomb (B&L), which is preparing to accept a rival proposal from Warburg Pincus and had asked AMO to improve its offer. AMO plans to evaluate and respond to B&L's revision request. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics